BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25422507)

  • 1. Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection.
    Buela KA; Hendricks RL
    J Immunol; 2015 Jan; 194(1):379-87. PubMed ID: 25422507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Neurokinin-1 Receptor Alters Ocular Surface Homeostasis and Promotes an Early Development of Herpes Stromal Keratitis.
    Gaddipati S; Rao P; Jerome AD; Burugula BB; Gerard NP; Suvas S
    J Immunol; 2016 Nov; 197(10):4021-4033. PubMed ID: 27798158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.
    Rowe AM; Yun H; Treat BR; Kinchington PR; Hendricks RL
    J Immunol; 2017 Feb; 198(4):1706-1717. PubMed ID: 28062697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis.
    Lepisto AJ; Xu M; Yagita H; Weinberg AD; Hendricks RL
    J Leukoc Biol; 2007 Mar; 81(3):766-74. PubMed ID: 17185358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.
    Jiang Y; Yin X; Stuart PM; Leib DA
    mBio; 2015 Oct; 6(6):e01426-15. PubMed ID: 26507231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection.
    Park SJ; Riccio RE; Kopp SJ; Ifergan I; Miller SD; Longnecker R
    mBio; 2020 May; 11(3):. PubMed ID: 32398314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients.
    Verjans GM; Remeijer L; van Binnendijk RS; Cornelissen JG; Völker-Dieben HJ; Baarsma SG; Osterhaus AD
    J Infect Dis; 1998 Feb; 177(2):484-8. PubMed ID: 9466544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.
    Xia L; Zhang S; Zhou J; Li Y
    Mol Vis; 2010 Oct; 16():2071-83. PubMed ID: 21042564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.
    Lepisto AJ; Frank GM; Xu M; Stuart PM; Hendricks RL
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3400-9. PubMed ID: 16877409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.
    Gaddipati S; Estrada K; Rao P; Jerome AD; Suvas S
    J Immunol; 2015 Jan; 194(1):273-82. PubMed ID: 25411200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans.
    Koelle DM; Reymond SN; Chen H; Kwok WW; McClurkan C; Gyaltsong T; Petersdorf EW; Rotkis W; Talley AR; Harrison DA
    J Virol; 2000 Dec; 74(23):10930-8. PubMed ID: 11069987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.
    Thomas J; Gangappa S; Kanangat S; Rouse BT
    J Immunol; 1997 Feb; 158(3):1383-91. PubMed ID: 9013983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.
    Bauer D; Schmitz A; Van Rooijen N; Steuhl KP; Heiligenhaus A
    Immunology; 2002 Sep; 107(1):118-28. PubMed ID: 12225370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.
    Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection.
    Kuffova L; Knickelbein JE; Yu T; Medina C; Amescua G; Rowe AM; Hendricks RL; Forrester JV
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1578-87. PubMed ID: 27050878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK).
    Jun H; Seo SK; Jeong HY; Seo HM; Zhu G; Chen L; Choi IH
    FEBS Lett; 2005 Nov; 579(27):6259-64. PubMed ID: 16253242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
    Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
    Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.
    Thomas J; Rouse BT
    J Immunol; 1998 Apr; 160(8):3965-70. PubMed ID: 9558104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
    Doymaz MZ; Rouse BT
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.